Otonomy prices upsized IPO at $16, the high end of the range

By
A A A

Otonomy, a late-stage biotech developing sustained-exposure treatments for ear diseases, raised $100 million in an upsized IPO by offering 6.3 million shares at $16.00, at the high end of the range of $14.00 to $16.00. The company originally planned to offer 5.3 million shares. Otonomy plans to list on the NASDAQ under the symbol OTIC. Otonomy initially filed confidentially on 6/5/2014. J.P. Morgan and BofA Merrill Lynch acted as lead managers on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks:

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

Most Active by Volume

100,376,898
  • $17.62 ▲ 0.51%
83,231,837
  • $25.62 ▲ 1.91%
75,739,329
  • $111.78 ▼ 0.77%
65,297,937
  • $36.37 ▼ 1.76%
59,053,093
  • $47.66 ▲ 0.29%
53,482,350
  • $2.59 ▼ 0.38%
51,504,284
  • $7.34 ▲ 2.37%
51,434,656
  • $8.14 ▲ 6.96%
As of 12/19/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com